Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
Tags:
FDA, clinical trials, Sarepta Therapeutics, Bridge Bio, Sanofi, Merck KGaA, Pfizer, Novo Nordisk, Verve Therapeutics, Roche, Vertex Pharmaceuticals, JNJ, Bristol Myers Squibb, ATTR-CM, Elevidys, tolebrutinib, evobrutinib, danuglipron, tiragolumab, VX-548, lazertinib
ADA 2023 – Lilly unveils its triple threat
EP Vantage
Wed, 06/28/23 - 09:57 am
Tags:
Eli Lilly, Novo Nordisk, retatrutide, Wegovy, Mounjaro, obesity, clinical trials
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
Fierce Biotech
Tue, 06/27/23 - 10:36 pm
Tags:
Novo Nordisk, hemophilia, clinical trials, Pfizer, Roche, Hemlibra
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Mon, 06/26/23 - 10:00 am
Tags:
Eli Lilly, obesity, orforglipron, Pfizer, Novo Nordisk, Mounjaro
Novo Nordisk’s once-weekly insulin supersedes its once-daily counterparts
Clinical Trials Arena
Mon, 06/26/23 - 09:54 am
Tags:
Novo Nordisk, clinical trials, insulin, Icodec
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Yahoo/Reuters
Thu, 06/22/23 - 10:21 am
Tags:
Novo Nordisk, EMA, semaglutide, Ozempic, Wegovy, thyroid cancer, obesity, diabetes
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
CNBC
Tue, 06/20/23 - 09:54 pm
Tags:
Novo Nordisk, legal, Ozempic, Wegocy, knockoffs
Eli Lilly's Mounjaro is primed to surpass Novo Nordisk's popular diabetes and obesity duo: report
Fierce Pharma
Mon, 06/19/23 - 10:29 am
Tags:
Eli Lilly, Novo Nordisk, Mounjaro, semaglutide, diabetes, obesity
More payers could stanch off-label use of Ozempic
Medical Marketing and Media
Mon, 06/19/23 - 10:24 am
Tags:
Novo Nordisk, Ozempic, off-label, weight loss
Ro pauses advertising of weight loss drug Wegovy amid shortages
Stat
Mon, 06/12/23 - 11:34 pm
Tags:
telehealth, Novo Nordisk, Wegovy, pharma advertising
Novo Nordisk to invest over $2B in drug ingredient production
BioPharma Dive
Mon, 06/12/23 - 11:21 pm
Tags:
Novo Nordisk, drug manufacturing
Novo Nordisk Eyes a Bigger Piece of the Diabetes Market
Medical Devices and Diagnostics Industry
Tue, 06/6/23 - 04:13 pm
Tags:
Novo Nordisk, Biocorp, Bio Jag, diabetes
Novo Nordisk enters talks to buy device maker Biocorp
Medical Marketing and Media
Mon, 06/5/23 - 11:30 am
Tags:
Novo Nordisk, M&A, Medtech, Biocorp
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Mon, 06/5/23 - 10:07 am
Tags:
Pfizer, danuglipron, Novo Nordisk, Ozempic, weight loss
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement
Medwatch
Sun, 06/4/23 - 04:19 pm
Tags:
Novo Nordisk, insulin, diabetes, drug pricing
Novo Nordisk wins age discrimination case in US district court
Medwatch
Sun, 06/4/23 - 04:17 pm
Tags:
Novo Nordisk, age discrimination, legal, EEOC
Novo seeks a cardiovascular boost
EP Vantage
Thu, 06/1/23 - 11:23 am
Tags:
Novo Nordisk, Wegovy, Eli Lilly, Mounjaro
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
Tags:
obesity, weight loss, Novo Nordisk, Eli Lilly, Pfizer, Amgen
This Could Be Novo Nordisk's Next Big Weight-Loss Product
Motley Fool
Wed, 05/31/23 - 10:56 am
Tags:
Novo Nordisk, weight loss, Wegovy, oral Wegovy
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Tue, 05/30/23 - 10:07 am
Tags:
Pfizer, Novo Nordisk, clinical trials, hemophilia, marstacimab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.